Annual Retained Earnings
-$999.70 M
-$153.61 M-18.16%
31 December 2023
Summary:
CRISPR Therapeutics AG annual retained earnings is currently -$999.70 million, with the most recent change of -$153.61 million (-18.16%) on 31 December 2023. During the last 3 years, it has fallen by -$426.12 million (-74.29%). CRSP annual retained earnings is now -11796.94% below its all-time high of -$8.40 million, reached on 31 December 2014.CRSP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.33 B
-$85.94 M-6.92%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly retained earnings is currently -$1.33 billion, with the most recent change of -$85.94 million (-6.92%) on 30 September 2024. Over the past year, it has dropped by -$239.59 million (-22.00%). CRSP quarterly retained earnings is now -1932.96% below its all-time high of $72.49 million, reached on 30 June 2021.CRSP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.2% | -22.0% |
| 3 y3 years | -74.3% | -2330.4% |
| 5 y5 years | -242.9% | -420.5% |
CRSP Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -410.3% | at low | -2330.4% | at low |
| 5 y | 5 years | -410.3% | at low | -1933.0% | at low |
| alltime | all time | <-9999.0% | at low | -1933.0% | at low |
CRISPR Therapeutics AG Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.33 B(+6.9%) |
| June 2024 | - | -$1.24 B(+11.3%) |
| Mar 2024 | - | -$1.12 B(+11.7%) |
| Dec 2023 | -$999.70 M(+18.2%) | -$999.70 M(-8.2%) |
| Sept 2023 | - | -$1.09 B(+11.5%) |
| June 2023 | - | -$976.89 M(+8.6%) |
| Mar 2023 | - | -$899.15 M(+6.3%) |
| Dec 2022 | -$846.09 M(+331.9%) | -$846.09 M(+15.0%) |
| Sept 2022 | - | -$735.51 M(+31.1%) |
| June 2022 | - | -$560.97 M(+49.5%) |
| Mar 2022 | - | -$375.13 M(+91.5%) |
| Dec 2021 | -$195.91 M(-65.8%) | -$195.91 M(+258.4%) |
| Sept 2021 | - | -$54.67 M(-175.4%) |
| June 2021 | - | $72.49 M(-110.6%) |
| Mar 2021 | - | -$686.74 M(+19.7%) |
| Dec 2020 | -$573.58 M | -$573.58 M(+22.9%) |
| Sept 2020 | - | -$466.54 M(+24.7%) |
| June 2020 | - | -$374.10 M(+27.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$294.44 M(+31.0%) |
| Dec 2019 | -$224.71 M(-22.9%) | -$224.71 M(-12.0%) |
| Sept 2019 | - | -$255.25 M(-35.2%) |
| June 2019 | - | -$393.68 M(+15.8%) |
| Mar 2019 | - | -$339.98 M(+16.6%) |
| Dec 2018 | -$291.57 M(+132.4%) | -$291.57 M(+19.5%) |
| Sept 2018 | - | -$243.98 M(+26.2%) |
| June 2018 | - | -$193.27 M(+24.8%) |
| Mar 2018 | - | -$154.89 M(+23.5%) |
| Dec 2017 | -$125.44 M(+119.8%) | -$125.44 M(-0.1%) |
| Sept 2017 | - | -$125.58 M(+24.5%) |
| June 2017 | - | -$100.87 M(+28.4%) |
| Mar 2017 | - | -$78.56 M(+37.6%) |
| Dec 2016 | -$57.08 M(+68.4%) | -$57.08 M(-23.1%) |
| Sept 2016 | - | -$74.18 M(+24.2%) |
| June 2016 | - | -$59.72 M(+76.1%) |
| Dec 2015 | -$33.91 M(+303.5%) | -$33.91 M |
| Dec 2014 | -$8.40 M | - |
FAQ
- What is CRISPR Therapeutics AG annual retained earnings?
- What is the all time high annual retained earnings for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual retained earnings year-on-year change?
- What is CRISPR Therapeutics AG quarterly retained earnings?
- What is the all time high quarterly retained earnings for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly retained earnings year-on-year change?
What is CRISPR Therapeutics AG annual retained earnings?
The current annual retained earnings of CRSP is -$999.70 M
What is the all time high annual retained earnings for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual retained earnings is -$8.40 M
What is CRISPR Therapeutics AG annual retained earnings year-on-year change?
Over the past year, CRSP annual retained earnings has changed by -$153.61 M (-18.16%)
What is CRISPR Therapeutics AG quarterly retained earnings?
The current quarterly retained earnings of CRSP is -$1.33 B
What is the all time high quarterly retained earnings for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly retained earnings is $72.49 M
What is CRISPR Therapeutics AG quarterly retained earnings year-on-year change?
Over the past year, CRSP quarterly retained earnings has changed by -$239.59 M (-22.00%)